ARTICLE | Finance

Tel Aviv transit

California's Quark going for Tel Aviv IPO; Israel's BioLineRX wants to add NASDAQ

October 4, 2010 7:00 AM UTC

Functional genomics play Quark Pharmaceuticals Inc. is headed to Tel Aviv to launch its IPO while BioLineRx Ltd. (Tel Aviv:BLRX) is going the other way to add a NASDAQ listing.

Quark filed to raise up to $20 million on the Tel Aviv Stock Exchange despite the fact that its headquarters are in Fremont, Calif. Its primary R&D facilities are in the Weizmann Science Park in Ness Ziona, Israel...